Prognostic factors and preoperative therapy in resectable intrahepatic cholangiocarcinoma
- 4 February 2025
- journal article
- abstracts
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 5-13
Abstract
Objective. To identify prognostic factors and role of preoperative therapy for resectable intrahepatic cholangiocarcinoma (IHCC). Material and methods. We analyzed the results of surgical and combined treatment of IHCC between 1999 and 2023. Immediate and long-term outcomes were evaluated depending on negative prognostic factors and additional therapy. Results. The study included 195 patients. Postoperative complications grade ≥III were observed in 35 (17.9%) case. Mortality rate was 3.1% (n=6). Thirty-eight patients (19.5%) underwent treatment before surgery, 109 (55.9%) ones — after surgery. The median overall survival was 31 months, 5-year overall survival — 32.0%. The following factors worsened overall survival: node size ≥8 cm (HR 1.45; 95% CI 0.97—2.17), invasion (HR 1.63; 95% CI 1.07—2.47), multiple lesion (HR 1.51; 95% CI 1.00—2.28). R1 resection worsened disease-free survival (HR 1.88; 95% CI 1.14—3.10). Lymph node metastases decreased overall (HR 1.96; 95% CI 1.27- 3.04) and disease-free survival (HR 2.37; 95% CI 1.63—3.44). Two and more negative factors worsened overall (p=0.0013) and disease-free survival (p=0.0005). Absence of adjuvant therapy worsened overall (HR 2.12; 95% CI 1.41—3.20) and disease-free survival (HR 1.42; 95% CI 0.99—2.04). There was a trend towards higher overall (p=0.088) and progression-free survival (p=0.029) in case of preoperative therapy (n=195). In unfavorable prognosis group, preoperative therapy (n=33) was superior to standard treatment (resection+capecitabine after surgery, n=26). There was a trend towards higher overall survival (p=0.066) and significantly better progression-free survival (17 vs 13 months, p=0.018). Conclusion. Negative prognostic factors for resectable IHCC are lesion size ≥8 cm, intrahepatic and regional metastases, invasion into neighboring structures, R1 resection. Combination of negative factors worsened prognosis. Adjuvant therapy improved postoperative outcomes. Preoperative therapy may be advisable in case of negative factors and high risk of R1 resection.Keywords
This publication has 28 references indexed in Scilit:
- A surgical strategy for intrahepatic cholangiocarcinoma — the hilar first conceptLangenbeck's Archives of Surgery, 2023
- Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic CholangiocarcinomaWorld Journal of Surgery, 2023
- Comparison of Hepatic Arterial Infusion Pump Chemotherapy vs Resection for Patients With Multifocal Intrahepatic CholangiocarcinomaJAMA Surgery, 2022
- Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature reviewCancer Treatment and Research Communications, 2021
- Very Early Recurrence After Liver Resection for Intrahepatic CholangiocarcinomaJAMA Surgery, 2020
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic CholangiocarcinomaJAMA Oncology, 2020
- Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi‐institutional analysisJournal of Surgical Oncology, 2017
- Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas?Surgical Endoscopy, 2016
- Clinical prognostic significance of regional and extended lymphadenectomy for biliary cancer with para-aortic lymph node metastasis: A systematic review and meta-analysisDigestive and Liver Disease, 2016
- Is Para‐aortic Lymph Node Metastasis a Contraindication for Radical Resection in Biliary Carcinoma?World Journal of Surgery, 2011